Trials / Completed
CompletedNCT06000150
Characteristics of Trachomatous Corneal Opacity in Fayoum University Hospital
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Omar Said · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the characteristics of trachomatous corneal opacity in patients with signs of trachoma using Anterior segment Optic coherence tomography and Pentacam
Detailed description
After approval of the local institutional ethics committee and local institutional review board, patient presented to Fayoum University Hospital was examined for corneal opacity with signs of trachoma after a detailed informed consent was signed by eligible patients and investigated by Anterior Segment Optic coherence Tomography and Pentacam. Descriptive statistics were presented in the form of mean and standard deviation for numerical variables while numbers and percentages are used for the categorical variables. Paired samples t-test was used to study anterior segment Optic Coherence tomography and pentacam in evaluating corneal thickness. Bland-Altman plot was used to study the agreement between the two methods IBM SPSS version 28 for Windows software was used for the analysis and Stata 16 was used for the Bland-Altman plot. A p-value of \< 0.05 was considered significant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Corneal topography | AS-OCT,PENTACAM |
Timeline
- Start date
- 2022-02-01
- Primary completion
- 2022-08-30
- Completion
- 2022-08-30
- First posted
- 2023-08-21
- Last updated
- 2023-08-21
Locations
1 site across 1 country: Egypt
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06000150. Inclusion in this directory is not an endorsement.